Global Mesalamine API Sales Market Report 2023

Report ID: 845709 | Published Date: Jan 2025 | No. of Page: 141 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Mesalamine API Market Overview
    1.1 Mesalamine API Product Scope
    1.2 Mesalamine API Segment by Type
        1.2.1 Global Mesalamine API Sales by Type (2016 & 2021 & 2027)
        1.2.2 Purity ≥ 97 %
        1.2.3 Purity ≥ 98 %
        1.2.4 Purity ≥ 99 %
    1.3 Mesalamine API Segment by Application
        1.3.1 Global Mesalamine API Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Mesalamine Tablets
        1.3.3 Mesalamine Capsules
        1.3.4 Others
    1.4 Mesalamine API Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Mesalamine API Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Mesalamine API Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Mesalamine API Price Trends (2016-2027)

2 Mesalamine API Estimates and Forecasts by Region
    2.1 Global Mesalamine API Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Mesalamine API Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Mesalamine API Sales Market Share by Region (2016-2021)
        2.2.2 Global Mesalamine API Revenue Market Share by Region (2016-2021)
    2.3 Global Mesalamine API Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Mesalamine API Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Mesalamine API Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Mesalamine API Estimates and Projections (2016-2027)
        2.4.2 Europe Mesalamine API Estimates and Projections (2016-2027)
        2.4.3 China Mesalamine API Estimates and Projections (2016-2027)
        2.4.4 Japan Mesalamine API Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Mesalamine API Estimates and Projections (2016-2027)
        2.4.6 India Mesalamine API Estimates and Projections (2016-2027)
3 Global Mesalamine API Competition Landscape by Players
    3.1 Global Top Mesalamine API Players by Sales (2016-2021)
    3.2 Global Top Mesalamine API Players by Revenue (2016-2021)
    3.3 Global Mesalamine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mesalamine API as of 2020)
    3.4 Global Mesalamine API Average Price by Company (2016-2021)
    3.5 Manufacturers Mesalamine API Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Mesalamine API Market Size by Type
    4.1 Global Mesalamine API Historic Market Review by Type (2016-2021)
        4.1.1 Global Mesalamine API Sales Market Share by Type (2016-2021)
        4.1.2 Global Mesalamine API Revenue Market Share by Type (2016-2021)
        4.1.3 Global Mesalamine API Price by Type (2016-2021)
    4.2 Global Mesalamine API Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Mesalamine API Sales Forecast by Type (2022-2027)
        4.2.2 Global Mesalamine API Revenue Forecast by Type (2022-2027)
        4.2.3 Global Mesalamine API Price Forecast by Type (2022-2027)
5 Global Mesalamine API Market Size by Application
    5.1 Global Mesalamine API Historic Market Review by Application (2016-2021)
        5.1.1 Global Mesalamine API Sales Market Share by Application (2016-2021)
        5.1.2 Global Mesalamine API Revenue Market Share by Application (2016-2021)
        5.1.3 Global Mesalamine API Price by Application (2016-2021)
    5.2 Global Mesalamine API Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Mesalamine API Sales Forecast by Application (2022-2027)
        5.2.2 Global Mesalamine API Revenue Forecast by Application (2022-2027)
        5.2.3 Global Mesalamine API Price Forecast by Application (2022-2027)

6 North America Mesalamine API Market Facts & Figures
    6.1 North America Mesalamine API Sales by Company
        6.1.1 North America Mesalamine API Sales by Company (2016-2021)
        6.1.2 North America Mesalamine API Revenue by Company (2016-2021)
    6.2 North America Mesalamine API Sales Breakdown by Type
        6.2.1 North America Mesalamine API Sales Breakdown by Type (2016-2021)
        6.2.2 North America Mesalamine API Sales Breakdown by Type (2022-2027)
    6.3 North America Mesalamine API Sales Breakdown by Application
        6.3.1 North America Mesalamine API Sales Breakdown by Application (2016-2021)
        6.3.2 North America Mesalamine API Sales Breakdown by Application (2022-2027)

7 Europe Mesalamine API Market Facts & Figures
    7.1 Europe Mesalamine API Sales by Company
        7.1.1 Europe Mesalamine API Sales by Company (2016-2021)
        7.1.2 Europe Mesalamine API Revenue by Company (2016-2021)
    7.2 Europe Mesalamine API Sales Breakdown by Type
        7.2.1 Europe Mesalamine API Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Mesalamine API Sales Breakdown by Type (2022-2027)
    7.3 Europe Mesalamine API Sales Breakdown by Application
        7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)

8 China Mesalamine API Market Facts & Figures
    8.1 China Mesalamine API Sales by Company
        8.1.1 China Mesalamine API Sales by Company (2016-2021)
        8.1.2 China Mesalamine API Revenue by Company (2016-2021)
    8.2 China Mesalamine API Sales Breakdown by Type
        8.2.1 China Mesalamine API Sales Breakdown by Type (2016-2021)
        8.2.2 China Mesalamine API Sales Breakdown by Type (2022-2027)
    8.3 China Mesalamine API Sales Breakdown by Application
        8.3.1 China 315 Sales Breakdown by Application (2016-2021)
        8.3.2 China 315 Sales Breakdown by Application (2022-2027)

9 Japan Mesalamine API Market Facts & Figures
    9.1 Japan Mesalamine API Sales by Company
        9.1.1 Japan Mesalamine API Sales by Company (2016-2021)
        9.1.2 Japan Mesalamine API Revenue by Company (2016-2021)
    9.2 Japan Mesalamine API Sales Breakdown by Type
        9.2.1 Japan Mesalamine API Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Mesalamine API Sales Breakdown by Type (2022-2027)
    9.3 Japan Mesalamine API Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Mesalamine API Market Facts & Figures
    10.1 Southeast Asia Mesalamine API Sales by Company
        10.1.1 Southeast Asia Mesalamine API Sales by Company (2016-2021)
        10.1.2 Southeast Asia Mesalamine API Revenue by Company (2016-2021)
    10.2 Southeast Asia Mesalamine API Sales Breakdown by Type
        10.2.1 Southeast Asia Mesalamine API Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Mesalamine API Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Mesalamine API Sales Breakdown by Application
        10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Mesalamine API Market Facts & Figures
    11.1 India Mesalamine API Sales by Company
        11.1.1 India Mesalamine API Sales by Company (2016-2021)
        11.1.2 India Mesalamine API Revenue by Company (2016-2021)
    11.2 India Mesalamine API Sales Breakdown by Type
        11.2.1 India Mesalamine API Sales Breakdown by Type (2016-2021)
        11.2.2 India Mesalamine API Sales Breakdown by Type (2022-2027)
    11.3 India Mesalamine API Sales Breakdown by Application
        11.3.1 India Mesalamine API Sales Breakdown by Application (2016-2021)
        11.3.2 India Mesalamine API Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Mesalamine API Business
    12.1 Syntese A/S
        12.1.1 Syntese A/S Corporation Information
        12.1.2 Syntese A/S Business Overview
        12.1.3 Syntese A/S Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Syntese A/S Mesalamine API Products Offered
        12.1.5 Syntese A/S Recent Development
    12.2 Divis Laboratories
        12.2.1 Divis Laboratories Corporation Information
        12.2.2 Divis Laboratories Business Overview
        12.2.3 Divis Laboratories Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Divis Laboratories Mesalamine API Products Offered
        12.2.5 Divis Laboratories Recent Development
    12.3 Cambrex Corporation
        12.3.1 Cambrex Corporation Corporation Information
        12.3.2 Cambrex Corporation Business Overview
        12.3.3 Cambrex Corporation Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Cambrex Corporation Mesalamine API Products Offered
        12.3.5 Cambrex Corporation Recent Development
    12.4 Ipca Laboratories
        12.4.1 Ipca Laboratories Corporation Information
        12.4.2 Ipca Laboratories Business Overview
        12.4.3 Ipca Laboratories Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Ipca Laboratories Mesalamine API Products Offered
        12.4.5 Ipca Laboratories Recent Development
    12.5 PharmaZell
        12.5.1 PharmaZell Corporation Information
        12.5.2 PharmaZell Business Overview
        12.5.3 PharmaZell Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 PharmaZell Mesalamine API Products Offered
        12.5.5 PharmaZell Recent Development
    12.6 Lasa Loboratory
        12.6.1 Lasa Loboratory Corporation Information
        12.6.2 Lasa Loboratory Business Overview
        12.6.3 Lasa Loboratory Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Lasa Loboratory Mesalamine API Products Offered
        12.6.5 Lasa Loboratory Recent Development
    12.7 Erregierre SpA
        12.7.1 Erregierre SpA Corporation Information
        12.7.2 Erregierre SpA Business Overview
        12.7.3 Erregierre SpA Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Erregierre SpA Mesalamine API Products Offered
        12.7.5 Erregierre SpA Recent Development
    12.8 Corden Pharma Bergamo
        12.8.1 Corden Pharma Bergamo Corporation Information
        12.8.2 Corden Pharma Bergamo Business Overview
        12.8.3 Corden Pharma Bergamo Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Corden Pharma Bergamo Mesalamine API Products Offered
        12.8.5 Corden Pharma Bergamo Recent Development
    12.9 CTX Lifescience
        12.9.1 CTX Lifescience Corporation Information
        12.9.2 CTX Lifescience Business Overview
        12.9.3 CTX Lifescience Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 CTX Lifescience Mesalamine API Products Offered
        12.9.5 CTX Lifescience Recent Development
    12.10 Ishita Active Pharma Ingredients
        12.10.1 Ishita Active Pharma Ingredients Corporation Information
        12.10.2 Ishita Active Pharma Ingredients Business Overview
        12.10.3 Ishita Active Pharma Ingredients Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Ishita Active Pharma Ingredients Mesalamine API Products Offered
        12.10.5 Ishita Active Pharma Ingredients Recent Development
    12.11 YC Biotech (Jiangsu)
        12.11.1 YC Biotech (Jiangsu) Corporation Information
        12.11.2 YC Biotech (Jiangsu) Business Overview
        12.11.3 YC Biotech (Jiangsu) Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 YC Biotech (Jiangsu) Mesalamine API Products Offered
        12.11.5 YC Biotech (Jiangsu) Recent Development
    12.12 Xinxiang Tianfeng Fine Chemical
        12.12.1 Xinxiang Tianfeng Fine Chemical Corporation Information
        12.12.2 Xinxiang Tianfeng Fine Chemical Business Overview
        12.12.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Xinxiang Tianfeng Fine Chemical Mesalamine API Products Offered
        12.12.5 Xinxiang Tianfeng Fine Chemical Recent Development

13 Mesalamine API Manufacturing Cost Analysis
    13.1 Mesalamine API Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Mesalamine API
    13.4 Mesalamine API Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Mesalamine API Distributors List
    14.3 Mesalamine API Customers

15 Market Dynamics
    15.1 Mesalamine API Market Trends
    15.2 Mesalamine API Drivers
    15.3 Mesalamine API Market Challenges
    15.4 Mesalamine API Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Mesalamine API Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Mesalamine API Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Mesalamine API Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Mesalamine API Sales (MT) by Region (2016-2021)
    Table 5. Global Mesalamine API Sales Market Share by Region (2016-2021)
    Table 6. Global Mesalamine API Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Mesalamine API Revenue Share by Region (2016-2021)
    Table 8. Global Mesalamine API Sales (MT) Forecast by Region (2022-2027)
    Table 9. Global Mesalamine API Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Mesalamine API Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Mesalamine API Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Mesalamine API Sales (MT) of Key Companies (2016-2021)
    Table 13. Global Mesalamine API Sales Share by Company (2016-2021)
    Table 14. Global Mesalamine API Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Mesalamine API Revenue Share by Company (2016-2021)
    Table 16. Global Mesalamine API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine API as of 2020)
    Table 17. Global Mesalamine API Average Price (USD/Kg) of Key Company (2016-2021)
    Table 18. Manufacturers Mesalamine API Manufacturing Sites and Area Served
    Table 19. Manufacturers Mesalamine API Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Mesalamine API Sales (MT) by Type (2016-2021)
    Table 22. Global Mesalamine API Sales Share by Type (2016-2021)
    Table 23. Global Mesalamine API Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Mesalamine API Price (USD/Kg) by Type (2016-2021)
    Table 25. Global Mesalamine API Sales Share by Type (2022-2027)
    Table 26. Global Mesalamine API Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Mesalamine API Revenue Share by Type (2022-2027)
    Table 28. Global Mesalamine API Price (USD/Kg) by Type (2022-2027)
    Table 29. Global Mesalamine API Sales (MT) by Application (2016-2021) 
    Table 30. Global Mesalamine API Sales Share by Application (2016-2021)
    Table 31. Global Mesalamine API Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Mesalamine API Price (USD/Kg) by Application (2016-2021)
    Table 33. Global Mesalamine API Sales (MT) by Application (2022-2027)
    Table 34. Global Mesalamine API Sales Share by Application (2022-2027)
    Table 35. Global Mesalamine API Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Mesalamine API Revenue Share by Application (2022-2027)
    Table 37. Global Mesalamine API Price (USD/Kg) by Application (2022-2027)
    Table 38. North America Mesalamine API Sales (MT) by Company (2016-2021)
    Table 39. North America Mesalamine API Sales Market Share by Company (2016-2021)
    Table 40. North America Mesalamine API Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Mesalamine API Revenue Market Share by Company (2016-2021)
    Table 42. North America Mesalamine API Sales by Type (2016-2021) & (MT)
    Table 43. North America Mesalamine API Sales Market Share by Type (2016-2021)
    Table 44. North America Mesalamine API Sales by Type (2022-2027) & (MT)
    Table 45. North America Mesalamine API Sales Market Share by Type (2022-2027)
    Table 46. North America Mesalamine API Sales by Application (2016-2021) & (MT)
    Table 47. North America Mesalamine API Sales Market Share by Application (2016-2021)
    Table 48. North America Mesalamine API Sales by Application (2022-2027) & (MT)
    Table 49. North America Mesalamine API Sales Market Share by Application (2022-2027)
    Table 50. Europe Mesalamine API Sales (MT) by Company (2016-2021)
    Table 51. Europe Mesalamine API Sales Market Share by Company (2016-2021)
    Table 52. Europe Mesalamine API Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Mesalamine API Revenue Market Share by Company (2016-2021)
    Table 54. Europe Mesalamine API Sales by Type (2016-2021) & (MT)
    Table 55. Europe Mesalamine API Sales Market Share by Type (2016-2021)
    Table 56. Europe Mesalamine API Sales by Type (2022-2027) & (MT)
    Table 57. Europe Mesalamine API Sales Market Share by Type (2022-2027)
    Table 58. Europe Mesalamine API Sales by Application (2016-2021) & (MT)
    Table 59. Europe Mesalamine API Sales Market Share by Application (2016-2021)
    Table 60. Europe Mesalamine API Sales by Application (2022-2027) & (MT)
    Table 61. Europe Mesalamine API Sales Market Share by Application (2022-2027)
    Table 62. China Mesalamine API Sales (MT) by Company (2016-2021)
    Table 63. China Mesalamine API Sales Market Share by Company (2016-2021)
    Table 64. China Mesalamine API Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Mesalamine API Revenue Market Share by Company (2016-2021)
    Table 66. China Mesalamine API Sales by Type (2016-2021) & (MT)
    Table 67. China Mesalamine API Sales Market Share by Type (2016-2021)
    Table 68. China Mesalamine API Sales by Type (2022-2027) & (MT)
    Table 69. China Mesalamine API Sales Market Share by Type (2022-2027)
    Table 70. China Mesalamine API Sales by Application (2016-2021) & (MT)
    Table 71. China Mesalamine API Sales Market Share by Application (2016-2021)
    Table 72. China Mesalamine API Sales by Application (2022-2027) & (MT)
    Table 73. China Mesalamine API Sales Market Share by Application (2022-2027)
    Table 74. Japan Mesalamine API Sales (MT) by Company (2016-2021)
    Table 75. Japan Mesalamine API Sales Market Share by Company (2016-2021)
    Table 76. Japan Mesalamine API Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Mesalamine API Revenue Market Share by Company (2016-2021)
    Table 78. Japan Mesalamine API Sales by Type (2016-2021) & (MT)
    Table 79. Japan Mesalamine API Sales Market Share by Type (2016-2021)
    Table 80. Japan Mesalamine API Sales by Type (2022-2027) & (MT)
    Table 81. Japan Mesalamine API Sales Market Share by Type (2022-2027)
    Table 82. Japan Mesalamine API Sales by Application (2016-2021) & (MT)
    Table 83. Japan Mesalamine API Sales Market Share by Application (2016-2021)
    Table 84. Japan Mesalamine API Sales by Application (2022-2027) & (MT)
    Table 85. Japan Mesalamine API Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Mesalamine API Sales (MT) by Company (2016-2021)
    Table 87. Southeast Asia Mesalamine API Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Mesalamine API Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Mesalamine API Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Mesalamine API Sales by Type (2016-2021) & (MT)
    Table 91. Southeast Asia Mesalamine API Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Mesalamine API Sales by Type (2022-2027) & (MT)
    Table 93. Southeast Asia Mesalamine API Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Mesalamine API Sales by Application (2016-2021) & (MT)
    Table 95. Southeast Asia Mesalamine API Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Mesalamine API Sales by Application (2022-2027) & (MT)
    Table 97. Southeast Asia Mesalamine API Sales Market Share by Application (2022-2027)
    Table 98. India Mesalamine API Sales (MT) by Company (2016-2021)
    Table 99. India Mesalamine API Sales Market Share by Company (2016-2021)
    Table 100. India Mesalamine API Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Mesalamine API Revenue Market Share by Company (2016-2021)
    Table 102. India Mesalamine API Sales by Type (2016-2021) & (MT)
    Table 103. India Mesalamine API Sales Market Share by Type (2016-2021)
    Table 104. India Mesalamine API Sales by Type (2022-2027) & (MT)
    Table 105. India Mesalamine API Sales Market Share by Type (2022-2027)
    Table 106. India Mesalamine API Sales by Application (2016-2021) & (MT)
    Table 107. India Mesalamine API Sales Market Share by Application (2016-2021)
    Table 108. India Mesalamine API Sales by Application (2022-2027) & (MT)
    Table 109. India Mesalamine API Sales Market Share by Application (2022-2027)
    Table 110. Syntese A/S Corporation Information
    Table 111. Syntese A/S Description and Business Overview
    Table 112. Syntese A/S Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 113. Syntese A/S Mesalamine API Product
    Table 114. Syntese A/S Recent Development
    Table 115. Divis Laboratories Corporation Information
    Table 116. Divis Laboratories Description and Business Overview
    Table 117. Divis Laboratories Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 118. Divis Laboratories Mesalamine API Product
    Table 119. Divis Laboratories Recent Development
    Table 120. Cambrex Corporation Corporation Information
    Table 121. Cambrex Corporation Description and Business Overview
    Table 122. Cambrex Corporation Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 123. Cambrex Corporation Mesalamine API Product
    Table 124. Cambrex Corporation Recent Development
    Table 125. Ipca Laboratories Corporation Information
    Table 126. Ipca Laboratories Description and Business Overview
    Table 127. Ipca Laboratories Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 128. Ipca Laboratories Mesalamine API Product
    Table 129. Ipca Laboratories Recent Development
    Table 130. PharmaZell Corporation Information
    Table 131. PharmaZell Description and Business Overview
    Table 132. PharmaZell Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 133. PharmaZell Mesalamine API Product
    Table 134. PharmaZell Recent Development
    Table 135. Lasa Loboratory Corporation Information
    Table 136. Lasa Loboratory Description and Business Overview
    Table 137. Lasa Loboratory Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 138. Lasa Loboratory Mesalamine API Product
    Table 139. Lasa Loboratory Recent Development
    Table 140. Erregierre SpA Corporation Information
    Table 141. Erregierre SpA Description and Business Overview
    Table 142. Erregierre SpA Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 143. Erregierre SpA Mesalamine API Product
    Table 144. Erregierre SpA Recent Development
    Table 145. Corden Pharma Bergamo Corporation Information
    Table 146. Corden Pharma Bergamo Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 147. Corden Pharma Bergamo Description and Business Overview
    Table 148. Corden Pharma Bergamo Mesalamine API Product
    Table 149. Corden Pharma Bergamo Recent Development
    Table 150. CTX Lifescience Corporation Information
    Table 151. CTX Lifescience Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 152. CTX Lifescience Description and Business Overview
    Table 153. CTX Lifescience Mesalamine API Product
    Table 154. CTX Lifescience Recent Development
    Table 155. Ishita Active Pharma Ingredients Corporation Information
    Table 156. Ishita Active Pharma Ingredients Description and Business Overview
    Table 157. Ishita Active Pharma Ingredients Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 158. Ishita Active Pharma Ingredients Mesalamine API Product
    Table 159. Ishita Active Pharma Ingredients Recent Development
    Table 160. YC Biotech (Jiangsu) Corporation Information
    Table 161. YC Biotech (Jiangsu) Description and Business Overview
    Table 162. YC Biotech (Jiangsu) Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 163. YC Biotech (Jiangsu) Mesalamine API Product
    Table 164. YC Biotech (Jiangsu) Recent Development
    Table 165. Xinxiang Tianfeng Fine Chemical Corporation Information
    Table 166. Xinxiang Tianfeng Fine Chemical Description and Business Overview
    Table 167. Xinxiang Tianfeng Fine Chemical Mesalamine API Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 168. Xinxiang Tianfeng Fine Chemical Mesalamine API Product
    Table 169. Xinxiang Tianfeng Fine Chemical Recent Development
    Table 170. Production Base and Market Concentration Rate of Raw Material
    Table 171. Key Suppliers of Raw Materials
    Table 172. Mesalamine API Distributors List
    Table 173. Mesalamine API Customers List
    Table 174. Mesalamine API Market Trends
    Table 175. Mesalamine API Market Drivers
    Table 176. Mesalamine API Market Challenges
    Table 177. Mesalamine API Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mesalamine API Product Picture
    Figure 2. Global Mesalamine API Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Mesalamine API Sales Market Share by Application in 2021 & 2027
    Figure 6. Mesalamine Tablets Examples
    Figure 7. Mesalamine Capsules Examples
    Figure 8. Others Examples
    Figure 9. Global Mesalamine API Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Mesalamine API Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Mesalamine API Sales (MT) Growth Rate (2016-2027)
    Figure 12. Global Mesalamine API Price Trends Growth Rate (2016-2027) (USD/Kg)
    Figure 13. Global Mesalamine API Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Mesalamine API Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Mesalamine API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Mesalamine API Sales (MT) Growth Rate (2016-2027)
    Figure 17. Europe Mesalamine API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Mesalamine API Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Mesalamine API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Mesalamine API Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Mesalamine API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Mesalamine API Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Mesalamine API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Mesalamine API Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Mesalamine API Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Mesalamine API Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Mesalamine API Players Market Share by Revenue in Mesalamine API: 2016 & 2020
    Figure 28. Mesalamine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Mesalamine API Revenue Share by Type (2016-2021)
    Figure 30. Global Mesalamine API Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Mesalamine API Revenue Share by Application (2016-2021)
    Figure 32. Global Mesalamine API Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Mesalamine API Sales Market Share by Type in 2020
    Figure 34. North America Mesalamine API Sales Market Share by Application in 2020
    Figure 35. Europe Mesalamine API Sales Market Share by Type in 2020
    Figure 36. Europe Mesalamine API Sales Market Share by Application in 2020
    Figure 37. China Mesalamine API Sales Market Share by Type in 2020
    Figure 38. China Mesalamine API Sales Market Share by Application in 2020
    Figure 39. Japan Mesalamine API Sales Market Share by Type in 2020
    Figure 40. Japan Mesalamine API Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Mesalamine API Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Mesalamine API Sales Market Share by Application in 2020
    Figure 43. India Mesalamine API Sales Market Share by Type in 2020
    Figure 44. India Mesalamine API Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Mesalamine API 
    Figure 47. Manufacturing Process Analysis of Mesalamine API
    Figure 48. Mesalamine API Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Frequently Asked Questions
Mesalamine API report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Mesalamine API report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Mesalamine API report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Exemestane API

Appearance is white powder, molecular formula is C20H24O2, molecular weight is 296.4.
Read More

Bortezomib API

It is white solid in appearance, CAS number is 179324-69-7, and the molecular formula is C19H25BN ... Read More

Carboplatin API

It is an anti-tumor API with the appearance of transparent crystalline powder, the molecular form ... Read More